You have free access to this content

International Journal of Cancer

Cover image for International Journal of Cancer

1 May 2008

Volume 122, Issue 9

Pages viii–ix, 1923–2171

  1. Obituary

    1. Top of page
    2. Obituary
    3. Spotlight
    4. Fast Track
    5. Carcinogenesis
    6. Cancer Cell Biology
    7. Cancer Genetics
    8. Tumor Immunology
    9. Early Detection and Diagnosis
    10. Epidemiology
    11. Cancer Therapy
    12. Short Reports
    13. Letters to the Editor
    1. You have free access to this content
      Obituary (page viii)

      Norbert Fusenig

      Version of Record online: 25 FEB 2008 | DOI: 10.1002/ijc.23505

  2. Spotlight

    1. Top of page
    2. Obituary
    3. Spotlight
    4. Fast Track
    5. Carcinogenesis
    6. Cancer Cell Biology
    7. Cancer Genetics
    8. Tumor Immunology
    9. Early Detection and Diagnosis
    10. Epidemiology
    11. Cancer Therapy
    12. Short Reports
    13. Letters to the Editor
    1. You have free access to this content
      Spotlight (page ix)

      Caroline Seydel

      Version of Record online: 25 FEB 2008 | DOI: 10.1002/ijc.23526

  3. Fast Track

    1. Top of page
    2. Obituary
    3. Spotlight
    4. Fast Track
    5. Carcinogenesis
    6. Cancer Cell Biology
    7. Cancer Genetics
    8. Tumor Immunology
    9. Early Detection and Diagnosis
    10. Epidemiology
    11. Cancer Therapy
    12. Short Reports
    13. Letters to the Editor
    1. You have free access to this content
      Prohibitin silencing reverses stabilization of mitochondrial integrity and chemoresistance in ovarian cancer cells by increasing their sensitivity to apoptosis (pages 1923–1930)

      Rosalind C. Gregory-Bass, Moshood Olatinwo, Wei Xu, Roland Matthews, Jonathan K. Stiles, Kelwyn Thomas, Dong Liu, Benjamin Tsang and Winston E. Thompson

      Version of Record online: 8 JAN 2008 | DOI: 10.1002/ijc.23351

    2. You have free access to this content
      17β-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer (pages 1931–1940)

      Joanna M. Day, Paul A. Foster, Helena J. Tutill, Michael F.C. Parsons, Simon P. Newman, Surinder K. Chander, Gillian M. Allan, Harshani R. Lawrence, Nigel Vicker, Barry V.L. Potter, Michael J. Reed and Atul Purohit

      Version of Record online: 8 JAN 2008 | DOI: 10.1002/ijc.23350

    3. You have free access to this content
      Evidence of a novel docetaxel sensitizer, garlic-derived S-allylmercaptocysteine, as a treatment option for hormone refractory prostate cancer (pages 1941–1948)

      Edward W. Howard, Davy T. Lee, Yung Tuen Chiu, Chee Wai Chua, Xianghong Wang and Yong Chuan Wong

      Version of Record online: 8 JAN 2008 | DOI: 10.1002/ijc.23355

  4. Carcinogenesis

    1. Top of page
    2. Obituary
    3. Spotlight
    4. Fast Track
    5. Carcinogenesis
    6. Cancer Cell Biology
    7. Cancer Genetics
    8. Tumor Immunology
    9. Early Detection and Diagnosis
    10. Epidemiology
    11. Cancer Therapy
    12. Short Reports
    13. Letters to the Editor
    1. You have free access to this content
      The molecular etiology of breast cancer: Evidence from biomarkers of risk (pages 1949–1957)

      Nilesh W. Gaikwad, Li Yang, Paola Muti, Jane L. Meza, Sandhya Pruthi, James N. Ingle, Eleanor G. Rogan and Ercole L. Cavalieri

      Version of Record online: 20 DEC 2007 | DOI: 10.1002/ijc.23329

    2. You have free access to this content
      Tumorigenicity and genotoxicity of an environmental pollutant 2,7-dinitrofluorene after systemic administration at a low dose level to female rats (pages 1958–1965)

      Danuta Malejka-Giganti, Daniel R. Parkin, Richard W. Decker, Gloria A. Niehans, Robin L. Bliss, Mona I. Churchwell and Frederick A. Beland

      Version of Record online: 8 JAN 2008 | DOI: 10.1002/ijc.23352

    3. You have free access to this content
      The combination of epigallocatechin gallate and curcumin suppresses ERα-breast cancer cell growth in vitro and in vivo (pages 1966–1971)

      Tiffany J. Somers-Edgar, Marissa J. Scandlyn, Emma C. Stuart, Martin J. Le Nedelec, Sophie P. Valentine and Rhonda J. Rosengren

      Version of Record online: 20 DEC 2007 | DOI: 10.1002/ijc.23328

  5. Cancer Cell Biology

    1. Top of page
    2. Obituary
    3. Spotlight
    4. Fast Track
    5. Carcinogenesis
    6. Cancer Cell Biology
    7. Cancer Genetics
    8. Tumor Immunology
    9. Early Detection and Diagnosis
    10. Epidemiology
    11. Cancer Therapy
    12. Short Reports
    13. Letters to the Editor
    1. You have free access to this content
    2. You have free access to this content
      Magnetic resonance imaging-based detection of glial brain tumors in mice after antiangiogenic treatment (pages 1981–1986)

      An Claes, Giulio Gambarota, Bob Hamans, Olaf van Tellingen, Pieter Wesseling, Cathy Maass, Arend Heerschap and William Leenders

      Version of Record online: 14 DEC 2007 | DOI: 10.1002/ijc.23306

    3. You have free access to this content
    4. You have free access to this content
    5. You have free access to this content
      hGPR87 contributes to viability of human tumor cells (pages 2008–2016)

      Sebastian Glatt, Daniel Halbauer, Stefan Heindl, Andreas Wernitznig, Daniela Kozina, Kuan-Chung Su, Christina Puri, Pilar Garin-Chesa and Wolfgang Sommergruber

      Version of Record online: 8 JAN 2008 | DOI: 10.1002/ijc.23349

  6. Cancer Genetics

    1. Top of page
    2. Obituary
    3. Spotlight
    4. Fast Track
    5. Carcinogenesis
    6. Cancer Cell Biology
    7. Cancer Genetics
    8. Tumor Immunology
    9. Early Detection and Diagnosis
    10. Epidemiology
    11. Cancer Therapy
    12. Short Reports
    13. Letters to the Editor
    1. You have free access to this content
      International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers (pages 2017–2022)

      Kelly A. Metcalfe, Daphna Birenbaum-Carmeli, Jan Lubinski, Jacek Gronwald, Henry Lynch, Pal Moller, Parviz Ghadirian, William D. Foulkes, Jan Klijn, Eitan Friedman, Charmaine Kim-Sing, Peter Ainsworth, Barry Rosen, Susan Domchek, Teresa Wagner, Nadine Tung, Siranoush Manoukian, Fergus Couch, Ping Sun, Steven A. Narod and and the Hereditary Breast Cancer Clinical Study Group

      Version of Record online: 14 JAN 2008 | DOI: 10.1002/ijc.23340

    2. You have free access to this content
  7. Tumor Immunology

    1. Top of page
    2. Obituary
    3. Spotlight
    4. Fast Track
    5. Carcinogenesis
    6. Cancer Cell Biology
    7. Cancer Genetics
    8. Tumor Immunology
    9. Early Detection and Diagnosis
    10. Epidemiology
    11. Cancer Therapy
    12. Short Reports
    13. Letters to the Editor
    1. You have free access to this content
      The possible role of factor H in colon cancer resistance to complement attack (pages 2030–2037)

      Ewa Wilczek, Robert Rzepko, Dominika Nowis, Magdalena Legat, Jakub Golab, Marta Glab, Adam Gorlewicz, Filip Konopacki, Michal Mazurkiewicz, Dariusz Sladowski, Barbara Gornicka, Aleksander Wasiutynski and Grzegorz M. Wilczynski

      Version of Record online: 8 JAN 2008 | DOI: 10.1002/ijc.23238

    2. You have free access to this content
      Plac1 is a tumor-specific antigen capable of eliciting spontaneous antibody responses in human cancer patients (pages 2038–2043)

      Xue-Yuan Dong, Ji-Run Peng, Ying-Jiang Ye, Hong-Song Chen, Li-Jie Zhang, Xue-Wen Pang, Yan Li, Yu Zhang, Shan Wang, Michael E. Fant, Yan-Hui Yin and Wei-Feng Chen

      Version of Record online: 8 JAN 2008 | DOI: 10.1002/ijc.23341

  8. Early Detection and Diagnosis

    1. Top of page
    2. Obituary
    3. Spotlight
    4. Fast Track
    5. Carcinogenesis
    6. Cancer Cell Biology
    7. Cancer Genetics
    8. Tumor Immunology
    9. Early Detection and Diagnosis
    10. Epidemiology
    11. Cancer Therapy
    12. Short Reports
    13. Letters to the Editor
    1. You have free access to this content
      Diagnostic targeting of colon cancer using a novel fluorescent somatostatin conjugate in a mouse xenograft model (pages 2044–2049)

      Genady Kostenich, Mor Oron-Herman, Sol Kimel, Nurit Livnah, Ilan Tsarfaty and Arie Orenstein

      Version of Record online: 8 JAN 2008 | DOI: 10.1002/ijc.23353

    2. You have free access to this content
      Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer (pages 2050–2056)

      Zheng-Sheng Wu, Qiang Wu, Jiu-Hua Yang, Hong-Qun Wang, Xiang-Dong Ding, Feng Yang and Xiao-Chun Xu

      Version of Record online: 2 JAN 2008 | DOI: 10.1002/ijc.23337

  9. Epidemiology

    1. Top of page
    2. Obituary
    3. Spotlight
    4. Fast Track
    5. Carcinogenesis
    6. Cancer Cell Biology
    7. Cancer Genetics
    8. Tumor Immunology
    9. Early Detection and Diagnosis
    10. Epidemiology
    11. Cancer Therapy
    12. Short Reports
    13. Letters to the Editor
    1. You have free access to this content
      Plasma vitamin B12 concentrations and the risk of colorectal cancer: A nested case-referent study (pages 2057–2061)

      Anna M. Dahlin, Bethany Van Guelpen, Johan Hultdin, Ingegerd Johansson, Göran Hallmans and Richard Palmqvist

      Version of Record online: 18 DEC 2007 | DOI: 10.1002/ijc.23299

    2. You have free access to this content
      Non-Hodgkin lymphoma and obesity: A pooled analysis from the InterLymph Consortium (pages 2062–2070)

      Eleanor V. Willett, Lindsay M. Morton, Patricia Hartge, Nikolaus Becker, Leslie Bernstein, Paolo Boffetta, Paige Bracci, James Cerhan, Brian C.-H. Chiu, Pierluigi Cocco, Luigino Dal Maso, Scott Davis, Silvia De Sanjose, Karin Ekstrom Smedby, Maria Grazia Ennas, Lenka Foretova, Elizabeth A. Holly, Carlo La Vecchia, Keitaro Matsuo, Marc Maynadie, Mads Melbye, Eva Negri, Alexandra Nieters, Richard Severson, Susan L. Slager, John J. Spinelli, Anthony Staines, Renato Talamini, Martine Vornanen, Dennis D. Weisenburger, Eve Roman and for the Interlymph Consortium

      Version of Record online: 31 DEC 2007 | DOI: 10.1002/ijc.23344

    3. You have free access to this content
      Coffee, tea, caffeine and risk of breast cancer: A 22-year follow-up (pages 2071–2076)

      Davaasambuu Ganmaa, Walter C. Willett, Tricia Y. Li, Diane Feskanich, Rob M. van Dam, Esther Lopez-Garcia, David J. Hunter and Michelle D. Holmes

      Version of Record online: 8 JAN 2008 | DOI: 10.1002/ijc.23336

    4. You have free access to this content
      Haplotype and genotypes of the VDR gene and cutaneous melanoma risk in non-Hispanic whites in Texas: A case–control study (pages 2077–2084)

      Chunying Li, Zhensheng Liu, Li E. Wang, Jeffrey E. Gershenwald, Jeffrey E. Lee, Victor G. Prieto, Madeleine Duvic, Elizabeth A. Grimm and Qingyi Wei

      Version of Record online: 8 JAN 2008 | DOI: 10.1002/ijc.23357

    5. You have free access to this content
      Second primary neoplasms in survivors of Wilms' tumour—A population-based cohort study from the British Childhood Cancer Survivor Study (pages 2085–2093)

      Aliki J. Taylor, David L. Winter, Kathy Pritchard-Jones, Charles A. Stiller, Clare Frobisher, Emma R. Lancashire, Raoul C. Reulen, Mike M. Hawkins and on behalf of the British Childhood Cancer Survivor Study

      Version of Record online: 14 JAN 2008 | DOI: 10.1002/ijc.23333

    6. You have free access to this content
      Acrylamide exposure and incidence of breast cancer among postmenopausal women in the Danish Diet, Cancer and Health Study (pages 2094–2100)

      Pelle Thonning Olesen, Anja Olsen, Henrik Frandsen, Kirsten Frederiksen, Kim Overvad and Anne Tjønneland

      Version of Record online: 8 JAN 2008 | DOI: 10.1002/ijc.23359

    7. You have free access to this content
      Polymorphisms in XPC and ERCC2 genes, smoking and breast cancer risk (pages 2101–2105)

      Roy E. Shore, Anne Zeleniuch-Jacquotte, Diane Currie, Harvey Mohrenweiser, Yelena Afanasyeva, Karen L. Koenig, Alan A. Arslan, Paolo Toniolo and Isaac Wirgin

      Version of Record online: 14 JAN 2008 | DOI: 10.1002/ijc.23361

    8. You have free access to this content
      Time-space trends in cancer incidence in The Netherlands in 1989–2003 (pages 2106–2114)

      Sabine Siesling, Maaike A. van der Aa, Jan W.W. Coebergh, Eero Pukkala and on behalf of the Working Group of The Netherlands Cancer Registry

      Version of Record online: 8 JAN 2008 | DOI: 10.1002/ijc.23358

  10. Cancer Therapy

    1. Top of page
    2. Obituary
    3. Spotlight
    4. Fast Track
    5. Carcinogenesis
    6. Cancer Cell Biology
    7. Cancer Genetics
    8. Tumor Immunology
    9. Early Detection and Diagnosis
    10. Epidemiology
    11. Cancer Therapy
    12. Short Reports
    13. Letters to the Editor
    1. You have free access to this content
    2. You have free access to this content
      Combination of serum hCGβ and p53 tissue expression defines distinct subgroups of serous ovarian carcinoma (pages 2125–2129)

      Juhani Vartiainen, Heini Lassus, Pentti Lehtovirta, Patrik Finne, Henrik Alfthan, Ralf Butzow and Ulf-Håkan Stenman

      Version of Record online: 20 DEC 2007 | DOI: 10.1002/ijc.23322

    3. You have free access to this content
    4. You have free access to this content
      Increased antitumor potential of the raloxifene prodrug, raloxifene diphosphate (pages 2142–2147)

      Yoshinori Okamoto, Xiaoping Liu, Naomi Suzuki, Kanako Okamoto, Masashi Sekimoto, Y.R. Santosh Laxmi and Shinya Shibutani

      Version of Record online: 8 JAN 2008 | DOI: 10.1002/ijc.23362

    5. You have free access to this content
      Synergistic antitumor activity of the novel SN-38-incorporating polymeric micelles, NK012, combined with 5-fluorouracil in a mouse model of colorectal cancer, as compared with that of irinotecan plus 5-fluorouracil (pages 2148–2153)

      Takako Eguchi Nakajima, Masahiro Yasunaga, Yasuhiko Kano, Fumiaki Koizumi, Ken Kato, Tetsuya Hamaguchi, Yasuhide Yamada, Kuniaki Shirao, Yasuhiro Shimada and Yasuhiro Matsumura

      Version of Record online: 14 JAN 2008 | DOI: 10.1002/ijc.23381

  11. Short Reports

    1. Top of page
    2. Obituary
    3. Spotlight
    4. Fast Track
    5. Carcinogenesis
    6. Cancer Cell Biology
    7. Cancer Genetics
    8. Tumor Immunology
    9. Early Detection and Diagnosis
    10. Epidemiology
    11. Cancer Therapy
    12. Short Reports
    13. Letters to the Editor
    1. You have free access to this content
      COX-2 and p53 in human sinonasal cancer: COX-2 expression is associated with adenocarcinoma histology and wood-dust exposure (pages 2154–2159)

      Reetta Holmila, Diane Cyr, Danièle Luce, Pirjo Heikkilä, Michael Dictor, Torben Steiniche, Tuula Stjernvall, Jette Bornholdt, Håkan Wallin, Henrik Wolff and Kirsti Husgafvel-Pursiainen

      Version of Record online: 8 JAN 2008 | DOI: 10.1002/ijc.23360

    2. You have free access to this content
      Rectal gastrointestinal stromal tumors associated with a novel germline KIT mutation (pages 2160–2164)

      Agnieszka Woźniak, Piotr Rutkowski, Raf Sciot, Włodzimierz Ruka, Wanda Michej and Maria Debiec-Rychter

      Version of Record online: 8 JAN 2008 | DOI: 10.1002/ijc.23338

  12. Letters to the Editor

    1. Top of page
    2. Obituary
    3. Spotlight
    4. Fast Track
    5. Carcinogenesis
    6. Cancer Cell Biology
    7. Cancer Genetics
    8. Tumor Immunology
    9. Early Detection and Diagnosis
    10. Epidemiology
    11. Cancer Therapy
    12. Short Reports
    13. Letters to the Editor
    1. You have free access to this content
      One falsehood leads easily to another (pages 2165–2168)

      Roderick A.F. MacLeod, Wilhelm G. Dirks and Hans G. Drexler

      Version of Record online: 2 JAN 2008 | DOI: 10.1002/ijc.23327

    2. You have free access to this content
      Authentication of nasopharyngeal carcinoma tumor lines (pages 2169–2171)

      Sylvia Yat-Yee Chan, Kwong-Wai Choy, Sai-Wah Tsao, Qian Tao, Tao Tang, Grace Tin-Yun Chung and Kwok-Wai Lo

      Version of Record online: 14 JAN 2008 | DOI: 10.1002/ijc.23374

SEARCH

SEARCH BY CITATION